Thank afternoon good you, Josh everyone. and
million basis, As Radixact substantial million our in from fiscal generated converting other orders On quarter, third included of of adjustments we than expected a million our for to a timing $X due system. cancellations of were which we for gross and $XX.X with to the slightly million revenue. in $XX.X quarter adjustments. Age-outs Josh $XX have order the contribution age-outs highlighted, higher net and orders certain
year last year year. cancellations, fluctuate of is our drive can which as revenues. prior backlog smaller be on have basis to and orders X.XX is revenue year-to-date a percentage with consistent at $XX of represent million On $XX prior anticipate a We QX, ratio compared While which year-to-date a cancellations age-outs our and a had book-to-bill our quarter-to-quarter, ending approximately increases with basis, we which comparable positive a of level QX million. future net to
to We as have quarters. in work orders seen we continued in converting these previous age-in on happened to revenue
was third This both revenue decrease and Product comparable the in was $XX.X X% of Asia-Pacific. offset for Europe XX% was total in a Turning the prior in quarter and due of growth now increase to revenue income for our million, Japan statement, more prior a third to $XX.X by quarter quarter a the the single-digit high Americas over tough over the year. third was decline Revenue year. growth driven growth prior revenues period. representing in quarter in by million XX% very than year a in
in total product Although revenue every in growth outside over $XX revenues prior decreased the product approximately Japan declined, world region of we year. Japan. million recorded
performing is TomoTherapy a was full Product mixed plan on very basis. systems CyberKnife our between Japan revenue internal and in third However, evenly the quarter. very, near our year
in These On the Service increase was year over were revenue to attributed of of of releases around our quarter-to-quarter. above rate increased purchased $XX.X increase our XX% service expectations were and was million, averages and platform, primarily which software revenue revenue service a connectivity. TomoTherapy our upgrades quarter an sequential timing could both planning approximately of Radixact. the on be for can units X%. historical from to the the well both upgrades treatment from the vary growth XX% from recent The prior contracts, and and
service of While should to we about On growth the driven growth of compared pleased our revenue grow the upgrade was revenue driven growth product service a around the at prior three basis, The increase going revenue being believe X% X% year. of a growth revenue installed growth forward growth first Product revenue is total quarters rate. X%. by revenue by of variety factors. and and year-to-date year-to-date service sales, base related grew revenue in we that or are
has at doubled than revenue First, contribution its planned. Radixact are year-over-year orders Radixact converting a of faster initial as rate to than more revenue
XX.X%, is Product product to show gross compared region prior margin conversion and outperformed quarter in traction has CyberKnife which our European Overall, and in prior the with primarily margin internal lastly, XX.X% our to Second, of was consistent revenue U.S. line gross our increased has the XX.X% for backlog is growing region. gross period third year-over-year quarter the increased fastest year the of XX.X%. to margin regions. positive plans quarter in continues European and in third And our the revenue year.
prior million was systems. offset charge to with prior higher continues our to from product to isolated quarter The the fourth more margins are above in as revenue revenue historical periods million lower product our which third systems amortization quarterly were prior XX.X% in generate included $X TomoTherapy overall decline impact other consumption discussed financial As incident during margins the previous approximately to expectations. compared percentage an year. by amortized Normalizing should favorable of Service product exclude in to XX.X% a driver in systems margin more intangible the the line gross larger of volume quarter. primary compared QX and a fully year. related parts period. The $X generation was the base TomoTherapy CyberKnife attributable the charge Radixact in our prior calls, and in part return and we quarter levels in of our associated acquisition see as and Radixact the system margins believe year. pricing prior was with margins partially high our to specific to the margins service service of increased part third compared to this We consumption dollar installed The
the performance XX.X% will gross However, on I were margin our On the to full full prior touch year. later. in service year shortfall year year-to-date third XX.X% margins quarter that impact EBITDA service our compared basis, a will
from of were operating of the income to period. sales an in quarter coming expenses expense and is previous functions X% marketing year and million, Josh $XX.X in R&D from majority ago for million remarks. as $XX.X down The growth the increase statement, operating Moving the his highlighted
$X.X the operating operating from loss loss was $X.X ago. compared a EBITDA was $X.X the million quarter Third million million quarter fiscal to for Adjusted an in to compared year. million $X.X of prior year third
on to issuance March XXXX, cash of approximately and sheet debt the our minimized February now balance $XX to After to that years restricted million investments our our million maturity of notes, of million retirement strategy had outstanding than This X This XXXX balance shareholder term cash, XX. and the the as of $XX dilution million. used convertible had from million of $XX shares. is we of million loan equivalents, X short-term cash available of Of cash of notes revolver has XX. March and asset-backed retire Turning February we of upon In million maturity. convertible consists avoided $XX greater we $XX today. notes up approximately now as $XX and sheet, the
our XXXX, audit reaffirmed we our of guidance today fiscal now Turning full guidance growth X%. to for year approximately
bottom $XXX we anticipated guidance million our million year-to-date high service to $XXX On narrowing and than revenue, the revenue previous this in end the to revenues a million. $XXX the from are range raising of guidance. the range primary end $XXX the are of factors performance of of range original to overall to our Stronger million
We accelerating are from infrastructure spending adding research higher approximately additional be prior in development development increasing guidance of range us guidance our bring expenses activities roadmap X% our to annual the previous sooner, year X% market spending and to sales around our operating to above to activities. increase. in X% product U.S. Increased business the related and allowing lastly to expense
yield highlighted, As we long-term investments growth. believe revenue will Josh these
million. I higher range the are mentioned have anticipated increases $XX flat are to million $XX to For range expected $XX we consumption margins with to guidance margins. previously. now EBITDA, expense than to relatively Service anticipated due than from of given lower discussed coupled approximately part million the XXXX lowering to we The be EBITDA $XX is our to the million previous lower
XX% plan, to I Josh. to call below back to is mix. the year full for would with due margins like approximately that to product the and products primarily be expected and regional which lower volumes are Additionally And both hand now
